EPISODE · Jan 5, 2022 · 8 MIN
PBS Subsidies in Australia Will Lower Cost of Kesimpta & Why You Matter to the MS Community
from MS News & Perspectives · host MS News Today
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how people in Australia with multiple sclerosis (MS) and certain other medical conditions will have access to new and expanded medications — including Kesimpta — now listed on the Pharmaceutical Benefits Scheme (PBS).Plus, Price reads the column by Jamie Hughes, A Life in Letters, “Celebrity or Not, You Matter to the MS Community”.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/ =====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/
Embed this episode
NOW PLAYING
PBS Subsidies in Australia Will Lower Cost of Kesimpta & Why You Matter to the MS Community
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.